Acarbose 50 mg tablet is a generic prescription medicine for oral use, made by 6 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F). Protect from moisture.
Key facts
- Active ingredient (INN)
- Acarbose
- Brand
- Sold under the generic name
- Strength
- 50 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 500 tablets, 1000 tablets and 13 more
- Manufacturers
- Avet PharmaceuticalsIndiaStrides PharmaIndiaBryant Ranch PrepackPD-Rx PharmaceuticalsChartwell RXHikma Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F). Protect from moisture.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A10BF01 Acarbose
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 7 May 2008
- Identifiers
- RxCUI 199149, 199150, 200132DailyMed set ID 722ce9eb-8f7b-4651-a287-d53dd7ab3707, 29939129-7d09-4c22-bf3e-491a8a97f4c4, 656769ee-e292-4950-83df-a38e6b1a9d6e +4NDC 72789-132, 23155-148, 64380-759 +4Application ANDA078470, ANDA202271, ANDA090912
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 23155-148-01 | Avet PharmaceuticalsIndia | 16 April 2021 |
| 500 tablet in 1 bottle | 23155-148-05 | Avet PharmaceuticalsIndia | 16 April 2021 |
| 1000 tablet in 1 bottle | 23155-148-10 | Avet PharmaceuticalsIndia | 16 April 2021 |
| 100 tablet in 1 bottle, plastic | 64380-759-06 | Strides PharmaIndia | 10 December 2016 |
| 90 tablet in 1 bottle | 62135-454-90 | Chartwell RX | 31 January 2023 |
| 100 tablet in 1 bottle | 0054-0141-25 | Hikma Pharmaceuticals | 7 May 2008 |
| 30 tablet in 1 bottle | 63629-5698-1 | Bryant Ranch Prepack | 10 December 2016 |
| 90 tablet in 1 bottle | 63629-5698-2 | Bryant Ranch Prepack | 10 December 2016 |
| 100 tablet in 1 bottle | 63629-5698-3 | Bryant Ranch Prepack | 10 December 2016 |
| 30 tablet in 1 bottle | 71335-9725-1 | Bryant Ranch Prepack | 11 September 2023 |
| 90 tablet in 1 bottle | 71335-9725-2 | Bryant Ranch Prepack | 12 August 2024 |
| 100 tablet in 1 bottle | 71335-9725-3 | Bryant Ranch Prepack | 12 August 2024 |
| 100 tablet in 1 bottle, plastic | 72789-132-01 | PD-Rx Pharmaceuticals | 24 June 2026 |
| 30 tablet in 1 bottle, plastic | 72789-132-30 | PD-Rx Pharmaceuticals | 7 July 2023 |
| 60 tablet in 1 bottle, plastic | 72789-132-60 | PD-Rx Pharmaceuticals | 21 October 2020 |
| 90 tablet in 1 bottle, plastic | 72789-132-90 | PD-Rx Pharmaceuticals | 16 September 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 6 September 1995 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Acarbose
Clinical summary
Acarbose is an alpha-glucosidase inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is available as tablets for oral use. MedsAcross supplies Acarbose for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AcarboseFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Acarbose prescribing information (Strides Pharma) · U.S. National Library of Medicine, DailyMed
Need Acarbose 50 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.